These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 15548559

  • 1. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
    Evangelou N, DeLuca GC, Owens T, Esiri MM.
    Brain; 2005 Jan; 128(Pt 1):29-34. PubMed ID: 15548559
    [Abstract] [Full Text] [Related]

  • 2. [Spinal cord magnetic resonance imaging in multiple sclerosis: importance of determining degree of atrophy as a marker of disease course].
    De Seze J, Ayachi M, Stojkovic T, Gauvrit JY, Saint Michel T, Pruvo J, Vermersch P.
    Rev Neurol (Paris); 2000 May; 156(5):491-6. PubMed ID: 10844368
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A, Toledo EG, Alexander JS, Kelley RE.
    J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [Abstract] [Full Text] [Related]

  • 4. Measurement of spinal cord atrophy in multiple sclerosis.
    Lin X, Tench CR, Evangelou N, Jaspan T, Constantinescu CS.
    J Neuroimaging; 2004 Jul; 14(3 Suppl):20S-26S. PubMed ID: 15228756
    [Abstract] [Full Text] [Related]

  • 5. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

  • 6. Spinal cord imaging in multiple sclerosis.
    Tench CR, Morgan PS, Jaspan T, Auer DP, Constantinescu CS.
    J Neuroimaging; 2005 Aug; 15(4 Suppl):94S-102S. PubMed ID: 16385022
    [Abstract] [Full Text] [Related]

  • 7. Normalized upper cervical spinal cord atrophy in multiple sclerosis.
    Song F, Huan Y, Yin H, Ge Y, Wei G, Chang Y, Zhao H.
    J Neuroimaging; 2008 Jul; 18(3):320-7. PubMed ID: 18318794
    [Abstract] [Full Text] [Related]

  • 8. Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.
    Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA.
    J Neuroimaging; 2005 Jul; 15(4 Suppl):30S-45S. PubMed ID: 16385017
    [Abstract] [Full Text] [Related]

  • 9. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD.
    Ann Neurol; 2000 Dec; 48(6):893-901. PubMed ID: 11117546
    [Abstract] [Full Text] [Related]

  • 10. [Magnetic resonance imaging of spinal cord lesions in 22 multiple sclerosis patients].
    Kato H, Funakawa I, Hara K, Yasuda T, Terao A.
    Rinsho Shinkeigaku; 1994 Mar; 34(3):229-35. PubMed ID: 8200139
    [Abstract] [Full Text] [Related]

  • 11. HLA-DRB1*1501 and spinal cord magnetic resonance imaging lesions in multiple sclerosis.
    Sombekke MH, Lukas C, Crusius JB, Tejedor D, Killestein J, Arteta D, Martínez A, Uitdehaag BM, Knol DL, Peña AS, Geurts JJ, De Jager PL, Barkhof F, Vrenken H, Polman CH.
    Arch Neurol; 2009 Dec; 66(12):1531-6. PubMed ID: 20008659
    [Abstract] [Full Text] [Related]

  • 12. Impact of disease-modifying therapies on brain and spinal cord atrophy in multiple sclerosis.
    Rudick RA.
    J Neuroimaging; 2004 Jul; 14(3 Suppl):54S-64S. PubMed ID: 15228760
    [Abstract] [Full Text] [Related]

  • 13. [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
    Zivadinov R, Sepcić J.
    Lijec Vjesn; 2006 Jul; 128(9-10):295-308. PubMed ID: 17128669
    [Abstract] [Full Text] [Related]

  • 14. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A.
    Neurologia; 2000 Jul; 15(7):288-302. PubMed ID: 11075577
    [Abstract] [Full Text] [Related]

  • 15. Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology.
    Bergers E, Bot JC, van der Valk P, Castelijns JA, Lycklama a Nijeholt GJ, Kamphorst W, Polman CH, Blezer EL, Nicolay K, Ravid R, Barkhof F.
    Ann Neurol; 2002 May; 51(5):652-6. PubMed ID: 12112117
    [Abstract] [Full Text] [Related]

  • 16. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
    Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.
    Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
    [Abstract] [Full Text] [Related]

  • 17. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.
    DeLuca GC, Ebers GC, Esiri MM.
    Brain; 2004 May; 127(Pt 5):1009-18. PubMed ID: 15047586
    [Abstract] [Full Text] [Related]

  • 18. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 19. Brain and spinal cord atrophy in multiple sclerosis.
    Simon JH.
    Neuroimaging Clin N Am; 2000 Nov; 10(4):753-70 ,ix. PubMed ID: 11359723
    [Abstract] [Full Text] [Related]

  • 20. Clinical-magnetic resonance imaging correlations in multiple sclerosis.
    Zivadinov R, Leist TP.
    J Neuroimaging; 2005 Nov; 15(4 Suppl):10S-21S. PubMed ID: 16385015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.